Welcome to LookChem.com Sign In|Join Free
  • or
4-Oxazolecarboxylic acid, 5-[(1S)-1-amino-2-phenylethyl]-, methyl ester, mono(trifluoroacetate) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

403860-29-7

Post Buying Request

403860-29-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

403860-29-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 403860-29-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,3,8,6 and 0 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 403860-29:
(8*4)+(7*0)+(6*3)+(5*8)+(4*6)+(3*0)+(2*2)+(1*9)=127
127 % 10 = 7
So 403860-29-7 is a valid CAS Registry Number.

403860-29-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl (S)-5-(α-aminophenethyl)oxazole-4-carboxylate Trifluoroacetate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:403860-29-7 SDS

403860-29-7Relevant academic research and scientific papers

Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors

-

Page 57, (2010/02/06)

Heterocyclic amide derivatives, of formula (I): wherein —X-Y-Z- is selected from —S—CR4═CR5—, —CR4═CR5—S—, —O—CR4═CR5—, —CR4═CR5—O—, —N═CR4—S—, —S—CR4═N—, —NR6—CR4═CR5— and —CR4═CR5—NR6—; or a pharmaceutically acceptable salt or an in vivo hydrolysable ester thereof; (with provisos); possess glycogen phosphorylase inhibitory activity and accordingly have value in the treatment of disease states associated with increased glycogen phosphorylase activity. Processes for the manufacture of said heterocyclic amide derivatives and pharmaceutical compositions containing them are described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 403860-29-7